This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Allison, M. As Genzyme flounders, competitors and activist investors swoop in. Nat Biotechnol 28, 3–4 (2010). https://doi.org/10.1038/nbt0110-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0110-3
This article is cited by
-
Viral contamination in biologic manufacture and implications for emerging therapies
Nature Biotechnology (2020)
-
Serological and molecular investigation of 2117-like vesiviruses in cats
Archives of Virology (2018)
-
Production and Purification of Recombinant Glucocerebrosidase in Transgenic Rice Cell Suspension Cultures
Applied Biochemistry and Biotechnology (2017)
-
Production of α-L-iduronidase in maize for the potential treatment of a human lysosomal storage disease
Nature Communications (2012)